More Than $100 Million Was Billed for Medically Questionable Vascular Procedures, Government Watchdog Finds
What they're not telling you: The $100 Million Vascular Procedure Racket: How Medicare's Cost-Cutting Created an Incentive Structure for Unnecessary Surgery The Centers for Medicare & Medicaid Services accidentally built a machine that pays doctors tens of millions to perform procedures patients don't need. Nearly 140 doctors across the United States are billing Medicare for vascular procedures at rates so anomalous that the Department of Health and Human Services' Office of the Inspector General flagged them as "concerning" in a report released this month. The total haul: more than $100 million in questionable charges.
What the Documents Show
What makes this scandal coherent—and what ProPublica's 2023 investigation first documented—is that this isn't the result of individual criminal scheming. It's institutional design. CMS created the conditions for this boom almost two decades ago. Here's the mechanism: Around 2005, CMS wanted to reduce hospital costs by pushing certain minimally invasive vascular procedures out of hospital settings and into office-based facilities. The logic seemed sound—outpatient care should cost less.
Follow the Money
Instead, the agency inadvertently created a perverse incentive. Office-based procedures, particularly stent placements and atherectomies (the removal of plaque using a bladed catheter), generate high reimbursement rates. Unlike hospital settings where procedures are bundled and departmental margins matter, office-based doctors could bill each procedure individually. The payment structure favored volume and frequency. The result: a surge of procedures performed on peripheral artery disease patients who, according to medical experts cited in the investigation, may not have needed treatment at all. Peripheral artery disease affects millions of Americans—plaque buildup that narrows leg arteries.
What Else We Know
Most cases respond to conservative management: medication, exercise, monitoring. But if a patient walks into an office equipped with catheters and stents, and the reimbursement code is active, the bias shifts toward intervention. The OIG's analysis, which began in April 2024, directly cited ProPublica's reporting and confirmed the pattern. Dozens of doctors showed billing patterns wildly inconsistent with their peers—performing these procedures at rates that defy medical logic. Yet the report names no individual doctors, no specific practices, no clear enforcement action against identified billers. This is where the mainstream framing gets soft.
Primary Sources
- Source: ProPublica
- Category: Financial Fraud
- Cross-reference independently — don't take our word for it.
Disclosure: NewsAnarchist aggregates from public records, API feeds (Federal Register, CourtListener, MuckRock, Hacker News), and independent media. AI-assisted synthesis. Always verify primary sources linked above.